# Risk Assessment

Risk level: Low

- Selected slice: architecture-review
- Mode: architecture_review
- Manual review required: no blocker; orchestrator validation and normal owner review are sufficient.

## Summary
Docs-only architecture review. No production code, migrations, dependency files, frontend
UI files, source documents, scripts, protected Ralph config, or secret files were modified.

## Review Scope
- Previous architecture-review commit: `7908071`
- Current review head: `7707942`
- Product slices reviewed: `002G2-admin-user-action-permission-granularity`,
  `002I-object-level-permission-test-harness`, `002J-api-contract-test-harness`, and
  `002K-seed-data-and-demo-users`.

## Findings and Mitigation
- One Medium corrective issue was found in `002K`: demo seeding grants
  `tracer.lifecycle.run` through the shared `sales_team_user` role.
- Mitigation: created `docs/slices/002K2-demo-tracer-permission-isolation.md` and reset
  the next recommended implementation slice to that corrective work before Epic 003.

## Residual Risk
Low. The current run changes only review/planning docs and run artifacts. The product-code
risk is deferred into the corrective slice rather than changed directly in review mode.
